Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer - An adjusted measurement and its clinical significance

European Journal of Cardio-thoracic Surgery

Volumn 26, Issue 2, 2004, Pages 425-431

  Hsu, Chung Ping ^a,b,c   Miaw, Jen ^a,c   Shai, Sen Ei ^a,c   Chen, Chih Yi ^a,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Lung cancer; Telomerase; Telomere; Terminal restriction fragment length

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT; SAMPLING; SOUTHERN BLOTTING; SURVIVAL RATE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TISSUE SLICE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL RATE; TELOMERASE; TELOMERE;

EID: 3543141152     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.04.029     Document Type: Article

References (24)

1. Moyzis R.K., Buckingham J.M., Cram L.S., Dani M., Deaven L.L., Jones M.D., Meyne J., Ratliff R.L., Wu J.R. A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA. 85:1988;6622-6626
2. Cross S.H., Allshire R.C., McKay S.J., McGill N.I., Cooke H.J. Cloning of human telomeres by complementation in years. Nature. 338:1989;774-776
3. Blackburn E.H. Structure and function of telomeres. Nature. 350:1991;569-573
4. Buchkovich K.J., Greider C.W. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell. 134:1996;1443-1454
5. Bryan T.M., Englezou A., Dalla-Pozza L., RDunham M.A., Reddel R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med. 3:1997;1271-1274
6. Harley C.B. Telomere loss: mitotic clock or genetic time bomb? Mutat Res. 256:1991;271-281
7. Lingner J., Hughes T.R., Shevchenko A., Mann M., Lundblad V., Cech T.R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 276:1997;561-567
8. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J. The RNA component of human telomerase. Science. 269:1995;1236-1241
9. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M.B., Arruda I., Robinson M.O. A mammalian telomerase-associated protein. Science. 275:1997;973-977
10. Hsu C.P., Miaw J., Hsia J.Y., Shai S.E., Chen C.Y. Concordant expression of the telomerase associated genes in non-small cell lung cancer. Eur J Surg Oncol. 29:2003;594-599
11. Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., Haller D.G., Morrow M. AJCC cancer staging handbook. 6th ed.:2002;191-203 Springer, New York
12. Wright W.E., Shay J.W., Piatyszek M.A. Modification of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23:1995;3794-3795
13. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells with express telomerase activity. Eur Mol Biol Org J. 11:1992;1921-1929
14. de Lange T., Shiue L., Myers R.M., Cox D.R., Naylor S.L., Killery A.M., Varmus H.E. Structure and variability of human chromosome ends. Mol Cell Biol. 10:1990;518-527
15. Nakano K., Watney E., McDougall J.K. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am J Pathol. 153:1998;857-864
16. Takagi S., Kinouchi Y., Hiwatashi N., Chida M., Nagashima F., Takahashi S., Negoro K., Shimosegawa T., Toyota T. Telomerase shortening and the clinicopathologic characteristics of human colorectal carcinomas. Cancer. 86:1999;1431-1436
17. Zhang D.K., Ngan H.Y.S., Cheng R.Y.S., Cheung A.N.Y., Liu S.S., Tsao S.W. Clinical significance of telomerase activity and telomeric restriction fragment (TRF) in cervical cancer. Eur J Cancer. 35:1999;154-160
18. Chang L.Y., Lin S.C., Chang C.S., Wong Y.K., Hu Y.C., Chang K.W. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. J Oral Pathol Med. 28:1999;389-396
19. Marchetti A., Bertacca G., Buttitta F., Chella A., Quattrocolo G., Angeletti C.A., Bevilacqua G. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin Cancer Res. 5:1999;2077-2081
20. Wu X., Kemp B., Amos C.I., Honn S.E., Zhang W., Walsh G.L., Spitz M.R. Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer. Br J Cancer. 80:1999;453-457
21. Taga S., Osaki T., Ohgami A., Imoto H., Yasumoto K. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann Surg. 230:1999;715-720
22. Hirashima T., Komiya T., Nitta T., Kobayashi M., Masuda N., Matui K., Takada M., Kikui M., Yasumitu T., Ohno A., Nakagawa K., Fukuoka M., Kawase I. Prognostic significance of telomeric repeat length alterations in pathological stage I-III non-small cell lung cancer. Anticancer Res. 20:2000;2181-2187
23. Asai A., Kiyozuka Y., Yoshida R., Fujii T., Hioki K., Tsubura A. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs. Anticancer Res. 18:1998;1465-1472
24. Dunham M.A., Neumann A.A., Fasching C.L., Reddel R.R. Telomeric maintenance by recombination in human cells. Nat Genet. 26:2000;447-450